baber/WOPTO huggingface dataset:
Patent NZ-534530-A (NZ)
Title: Machine and method for inflating and sealing air-filled packing cushions
Inventor: PERKINS ANDREW
IPC: B65D81/07
Filed: 2003-02-13
Abstract: Machine and method for making air-filled packing cushions from a roll of prefabricated film material (11) having a longitudinally extending inflation channel (19) near one edge of the material and chambers (21, 22) which communicate with the channel (19) through laterally extending passageways (23). The film material is fed from the roll (28) to an inflation tube (52) which extends into the inflation channel, air is introduced into the chambers (21, 22) through the inflation tube (52) to inflate the cushions, and a longitudinally extending seal (89) is formed across the passageways (23) between the channels (19) and the chambers (21, 22) after the cushions are inflated.
Patent NZ-537052-A (NZ)
Title: Control of protozoa and protozoan cysts that harbor legionella
Inventor: WHITEKETTLE WILSON K
IPC: A61K31/66
Filed: 2003-05-27
Abstract: Use of an effective amount of a phosphonium salt in the manufacture of a medicament for controlling protozoa trophozoite and cysts is disclosed, wherein the phosphonium salt is represented by formula (R1)3 P+ R2·X", wherein R1 is an alkyl group having from 1-8 carbons and R2 comprises an n-alkyl group having from 6-20 carbon atoms and X" is an anion selected form the group consisting of halides, sulfates, nitrates, nitrites and mixtures thereof. Addition of phosphonium salts such as Tri-n-butyl-tetradecylphosphonium chloride to aqueous systems was found to be effective at killing both the protozoa trophozoites and cysts. By effectively killing both the protozoa trophozoites and cysts, bacterial organism such as Legionella cells harboured in both the trophozoites and cysts are killed.
Patent NZ-539894-A (NZ)
Title: Aqueous phenol-formaldehyde resoles that are colorless when cured
Inventor: DETLEFSEN WILLIAM D
IPC: C08G8/32
Filed: 2003-03-04
Abstract: An aqueous, high molecular weight resole solution produced by a condensation of a phenolic compound with an aldehyde in the presence of a metal chelating agent, a strong base and a phenolic carboxylate, followed by acidification of the solution to a desired pH with an acid is disclosed. The disclosure is directed to compositions and a process leading to colorless or light colored aqueous phenol-formaldehyde resoles. Unlike previous technologies, these compositions lead to clear, storage stable, fast curing, high molecular weight resins. These materials are also capable of producing composite wood panels with superior water absorption and thickness swell test results when soaked in water. The composition essentially consists of an aqueous copolymer of phenol, formaldehyde, and a phenolic carboxylate (e.g. salicylic acid). Methylol phenols are formed under alkaline conditions in the presence of metal chelating agents. These are then condensed into a polymer under alkaline, neutral, or acidic conditions. The finished aqueous polymer solution is then acidified to the desired pH using a benzoic acid or a phenol-carboxylic acid.
Patent NZ-541150-A (NZ)
Title: Method for forming functional layers
Inventor: KUNZ MARTIN
IPC: C08F8/00
Filed: 2003-12-15
Abstract: Disclosed is a method for forming a functional layer on an inorganic or organic substrate, wherein a) a low-temperature plasma, a corona discharge, high-energy radiation and/or flame treatment is caused to act on the inorganic or organic substrate, b) at least one activatable initiator or at least one activatable initiator and at least one ethylenically unsaturated compound is applied in the form of a melt, solution, suspension or emulsion to the substrate, there being incorporated in the activatable initiator and/or the ethylenically unsaturated compound at least one function-controlling group which results in the treated substrate's acquiring desired surface properties.
Patent NZ-541752-A (NZ)
Title: One-part moisture curable hot melt silane functional poly-alpha-olefin sealant composition
Inventor: WANG BING
IPC: C09K3/10
Filed: 2004-03-11
Abstract: Disclosed is a moisture curable sealant composition that includes silane functional poly-alpha-olefin polymer, thermoplastic elastomer, and tackifying agent.
Patent NZ-546567-A (NZ)
Title: Methods and apparatus of improving inter-sector and/or inter-cell handoffs in a multi-carrier wireless communications system
Inventor: LAROIA RAJIV
IPC: H04B1/38
Filed: 2004-10-15
Abstract: An apparatus, communications system, computer readable medium, a base station, and a method of operating a first base station transmitter, is disclosed. The method comprises: i) operating the first base station transmitter to transmit into a first frequency band, during a first period of time, during which the first base station transmitter does not transmit into a second frequency band; ii) operating the first base station transmitter to transmit into a second frequency band, during a second period of time, which is shorter than the first period of time, where the first base station transmits into the second frequency band for a period of time which is less than 1/N the period of time it transmits into the first frequency band, where N is a positive value greater than 2, and transmits into the second frequency band during the second period of time including concentrating at least 60 percent of the transmitted power on one or more tones occupying less than one fifth of the second frequency band; and iii) repeating steps i and ii.
Patent NZ-549834-A (NZ)
Title: Method and apparatus for acquiring and removing information regarding digital rights objects
Inventor: LEE BYUNG-RAE
IPC: G06F21/00
Filed: 2005-03-15
Abstract: A device is disclosed comprising an interface module communicably linked with a portable storage device; a public-key encryption module which performs authentication with the portable storage device connected via the interface module; an encryption key generation module which generates a session key and a hashing key which are shared with the portable storage device; and a digital rights management (DRM) agent which requests data on a right object from the portable storage device and receives processed data on the right object from the portable storage device. The right object contains a definition of a right to content, constraints to the right to content which allows at least partial access to content and a right to the right object itself.
Patent NZ-552040-A (NZ)
Title: Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
Inventor: NANJAN KARTHIGEYAN
Filed: 2006-12-13
Abstract: Disclosed is a method of producing a storage veterinary macrocyclic lactone formulation which includes at least one glyceryl acetate solvent and at least one co-solvent, characterized by the steps of (a) dissolving at least one macrocyclic lactone compound into a co-solvent, and (b) adding at least one additional glyceryl acetate solvent or at least one additional co-solvent to volume.
Patent NZ-560534-A (NZ)
Title: Process for the production of calcium compositions in a continuous fluid bed
Inventor: PIENE JAN YNGVAR
IPC: A61K9/16
Filed: 2006-03-06
Abstract: Disclosed is a process for producing a particulate material comprising a calcium-containing compound, the process comprises granulating a fluidized composition comprising the calcium-containing compound optionally together with one or more pharmaceutically acceptable excipients under fluidizing conditions in a continuous fluid bed apparatus.
Patent NZ-562672-A (NZ)
Title: Transferring media over a mobile network only if identifiers in a request are matched to those in a remote device memory
Inventor: PUGLIESE FRANCESCO
IPC: H04L12/22
Filed: 2006-04-26
Abstract: Disclosed is a method of controlling the transfer of media content between a user terminal and a remote device, the remote device being capable of capturing sounds and/or images, both the terminal and the device being capable of multimedia data transfer using a mobile telecommunications network. The method comprises the steps of: sending a request from the terminal to the device, the request having an identifier; establishing a link between the device and the terminal; and transferring media content captured by the device to the terminal. The transfer only takes place if the identifier is indicative of one of a plurality of authorised reference identifiers stored in a memory of the device.
Patent NZ-563105-A (NZ)
Title: Communications system
Inventor: BOYS JOHN TALBOT
IPC: H04B1/00
Filed: 2007-11-02
Abstract: An apparatus for generating and/or transmitting communications signals is provided. The apparatus comprises: means for generating signals at a first frequency; means for mixing the frequency of the generated signals from the first frequency down to a second frequency; and a near field antenna for receiving the signals at the second frequency and being provided sufficiently near to a wire transmission line so as to wirelessly couple to it.
Patent NZ-563457-A (NZ)
Title: [1,2,4]triazolo[4,3-a]pyridine derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
Inventor: LI JAMES J
IPC: A61K31/435
Filed: 2006-06-08
Abstract: Disclosed is imidazo- and triazolopyridine compounds of formula (I) wherein the substituents are disclosed within the specification or an enantiomer, diastereomer, solvate, salt or prodrug thereof. Also disclosed is the use of the compound of formula I in the preparation of a medicament for inhibiting the enzyme 11-beta-hydroxysteroid dehydrogenase type I. Also disclosed is the use of the compound of formula I for treating diabetes, hyperglycemia, obesity, dislipidemia, hypertension, cognitive impairment, arthritis, glaucoma and metabolic syndrome.
Patent NZ-566783-A (NZ)
Title: Slow-release composition, method for the preparation thereof, and use of the same
Inventor: BERTHOUMIEU DIDIER
IPC: A61K9/50
Filed: 2006-11-23
Abstract: Disclosed is a pharmaceutical or nutraceutical composition comprising at least one coated granule, with sustained release of an active ingredient. The coated granule being composed of a particle that comprises said active ingredient and is coated with at least two coatings, wherein they comprise a combination of excipients composed of at least one copolymer (a) of esters of acrylic acid and of methacrylic acid having a molar percentage of quaternary ammonium groups of less than or equal to 8 percent, in association with a second copolymer (b) of esters of acrylic acid and of methacrylic acid having a molar percentage of quaternary ammonium groups of greater than 8 percent in a ratio by weight (a)/(b) of from 60/40 to 80/20 and with an amount of (a) of from 2.5 percent to 5.0 percent by dry weight, based on the total weight of the composition. Also disclosed is the use of said composition for the preparation of a product for the treatment and/or prevention of deficiencies of minerals and oligoelements and a process to prepare said compositions.
Patent NZ-575594-A (NZ)
Title: Formwork system comprising an elongate endface structure made of plurality of flat frame members
Inventor: KRAYENHOFF MEROR
IPC: E04B2/84
Filed: 2006-08-18
Abstract: The invention is a formwork system and a method of using the formwork to construct rammed earth walls. The formwork comprises end panels which can be quickly assembled and disassembled to provide end stops to support side panels without the need for through-ties. The end panels comprise integral handholds for access to the full height of the formwork. The end panels are stackable, rotatable and interchangeable, such that one set of formwork may be used to create several different wall configurations. The finished wall contains an internal support structure and insulating core, without through- holes
Patent NZ-583349-A (NZ)
Title: Inhaler for powdered capsules with improved capsule breaching actuation to reduce force applied by user
Inventor: KUHN ROLF
IPC: A61M15/00
Filed: 2008-07-17
Abstract: Disclosed is an inhaler for inhaling powdered medicaments from capsules with improved operability. The inhaler comprises a lower part, and a plate that can be latched to the lower part, by means of which the lower part can be closed off. A capsule holder can be lowered into the lower part for holding capsules, and a mouthpiece that can be latched to the plate. An actuating member is set in motion from a resting position and interacts with at least one pin in a pin holder, that can be pushed into the capsule holder. The actuating member is in two parts, such that it comprises an outer actuating member providing a push-button for a user and an inner actuating member providing the pin holder, where- the outer actuating member is larger than the inner actuating member, and the outer actuating member is constructed such that the pin holder is situated above the point of application of the force and below the suspension of the push-button. A force of 10-25N have to be applied in order to perforate a capsule in the capsule holder by moving the outer actuating member.
Patent NZ-586982-A (NZ)
Title: Tamper evident closure with a frangible bridge and a stamped protrusion member
Inventor: WIN CHRISTOPHER CAMPBELL
IPC: B65D41/32
Filed: 2011-07-18
Abstract: Disclosed is a tamper evident closure (TEC) including a closure cap and at least one tamper evident ring forming a recessed space therein whereby the at least one tamper evident ring has a body with one end attached by at least one frangible bridge member to the cap. The at least one ring includes at least one protrusion member spaced there around such that the protrusion members are formed by being stamped and protrude into the recessed space.
Patent NZ-587098-A (NZ)
Title: Use of a rifamycin class antibiotic for treating diarrhea-associated Irritable Bowel Syndrome and hepatic encephalopathy
Inventor: FORBES WILLIAM
IPC: A01N43/40
Filed: 2009-02-26
Abstract: Disclosed herein is the use of a rifamycin class antibiotic in the preparation of a medicament for the treatment of bowel disease (BD) that provides a durability of antibiotic response in a patient, wherein the medicament is formulated for administration at a dose comprising 1650 mg/day for 14 days to a subject in need thereof, followed by removing the subject from treatment after the 14 days so as to result in a durability of response that comprises between about 12 weeks and about 24 weeks of adequate relief of symptoms, wherein the bowel disease comprises one or more of irritable bowel syndrome (IBS), uncontrolled diarrhea-associated Irritable Bowel Syndrome (dIBS), Crohn's disease, traveler's diarrhea, ulcerative colitis, enteritis, small intestinal bacterial overgrowth, chronic pancreatitis, pancreatic insufficiency, colitis, diverticular disease, hepatic encephalopathy, or pouchitis, and wherein the rifamycin class antibiotic preferably comprises rifaximin.
Patent NZ-588683-A (NZ)
Title: Using the angle of a distil end of a submerged pipe with a vertical to adjust backpressure in a CPAP system
Inventor: DIBLASI ROBERT
IPC: A61M16/00
Filed: 2009-04-08
Abstract: A breathing assistance apparatus (100) to create back pressure on a CPAP device is disclosed. The device varies the angle of a conduit to vary the back pressure which is especially useful where the patent is a premature baby. The device comprises a pressurized gas source (110), a container (160) comprising a liquid (165) and a conduit (145) immersed in the liquid. The conduit has proximal end (141) adapted for connection to the pressurized gas source, and a distal end (170) of the configured change the angle with respect to vertical. The conduit is also adapted for connection to a patient interface (130) intermediate the proximal and distal. .
Patent NZ-593358-A (NZ)
Title: A fan assembly with a body that is tiltable relative to a base
Inventor: GAMMACK PETER
IPC: F04D25/10
Filed: 2010-02-18
Abstract: A fan assembly for creating an air current comprises an air outlet (14) mounted on a stand (12). The stand (12) comprises a base (38, 40) and a body (42) tiltable relative to the base (38, 40). The fan assembly has a centre of gravity (CG) located so that when the base is located on a substantially horizontal support surface, the projection of the centre of gravity on the support surface is within the footprint of the base when the body is in a fully tilted position.
Patent NZ-593932-A (NZ)
Title: Vitamin d promoting sunscreen
Inventor: ARMSTRONG ERNEST T
IPC: A61K8/35
Filed: 2009-12-21
Abstract: ABSTRACT - 593932 The disclosure relates to a topical composition comprising: (a) one or more ultraviolet radiation (UVR) filtering agents selected from the group consisting of ultraviolet A (UVA) radiation filtering agents avobenzone, diethylamino hydroxyl hexyl benzoate, meradimate and ecamsule; and (b) at least one UVR filtering agent selected from the group consisting of ultraviolet B (UVB) radiation filtering agents octocrylene, oxybenzone, octisalate, benzophenone-4 and homosalate, wherein the UVR filtering agents are present in the composition in an amount effective to filter UVA when the composition is applied to the skin of an animal exposed to UVA; and wherein the composition is adapted to allow passage of sufficient radiation in approximately 295 to 315 nm range to permit production of an effective amount of vitamin D when the composition is applied to the skin of an animal exposed to UVB. The composition is particularly used in sunscreens promoting on the one hand vitamin D3 production, on the other hand protecting the skin against harmful ultraviolet radiation. Also described are compositions suitable for providing protection against ultraviolet radiation containing one or more active ultraviolet radiation absorber through which ultraviolet B radiation is permitted to enter the skin in an amount sufficient for the body to produce a healthful and disease-opposing quantity of vitamin D3 and chemical precursors thereof, wherein the ultraviolet radiation absorber may be selected from the group consisting of Benzophenone, 2,4-Dihydroxybenzophenone, 2,2',4,4'-Tetrahydroxybenzophenone, 2,2'- Dihydroxy- 4,4'-dimethoxybenzophenone, 2,2'-Dihydroxy-4-methoxybenzophenone, 2- Hydroxy-4-(Octyloxy)Benzophenone, 4-Methyibenzylidene camphor, Cinoxate, Octinoxate, Diethanolamine p-methoxycinnamate, lsoamyl p-methoxycinnamate, Dibenzoylmethane, Bisoctrizole, Zinc oxide, Titanium dioxide, Cerium(IV), Ensulizole, Aminobenzoic acid, Padimate-O, Padimate-A, Glyceryl Aminobenzoate, Ethylhexyl Triazone, Trolamine Salicylate, Drometrizole Trisiloxane, Bemotrizinol, Iscotrizinol, Digalloyl trioleate, and mixtures thereof.
Patent NZ-595747-A (NZ)
Title: Novel quinazolinones and related compounds for use as anti-inflammatory agents
Inventor: HANSEN C HENRIK
IPC: C07D471/04
Filed: 2010-03-16
Abstract: Disclosed are 5,7-dimethoxy-2-phenyl-4-oxo-3,4-dihydroquinazolines and analogues thereof or a stereoisomer, tautomer, pharmaceutically acceptable salt, or hydrate thereof, wherein: Q is selected from CR12 and nitrogen; V is selected from CH and nitrogen; U is C=O; -X-(Z)n-G is selected from 1-[(dimethylamino)carbonyl]piperidin-4-yloxy, 1-acetylpiperidin-4-yloxy, 2-(isoindolin-2-yl)ethoxy, (4-acetylpiperazin-1-yl)ethoxy, (1H-imidazol-1-yl)ethoxy, (piperidin-1-yl)ethoxy, 2-(1-isopropyl-2,4-dioxo-imidazolidin-3-yl)-ethoxy, 2-(5-phenyl-2,4-dioxo-imidazolidin-3-yl)-ethoxy, (2,4-dioxo-imidazolidin-3-yl)methyl, 2-(azepan-1-yl)ethoxy, 2-(azetidin-1-yl)ethoxy, 2-(3-(acetylamino)-azetidin-1-yl)ethoxy, (5-oxopyrrolidin-2-yl)methoxy, [4-{ acetyl(isopropyl)amino} piperidin-1-yl]methyl, (4-(isopropylamino)piperidin-1-yl)methyl, 2-(2,5-dioxo-pyrrolidin-1-yl)ethoxy and (1H-tetrazol-5-yl)methyl; R12 is selected from hydrogen, alkoxy, and halogen; Rc is selected from hydrogen and (pyrrolidin-1-yl)propyl; Ra1, Ra2, and Ra3 are independently selected from hydrogen, alkyl, alkoxy, halogen, and heterocycle; Rb2 and Rb6 are hydrogen; and Rb3 and Rb5 are independently selected from hydrogen and alkyl; provided that at least one of Ra1, Ra2, and Ra3 is not hydrogen; if Ra2 or Ra3 is chloro, then Ra1 is not hydrogen; with at least one proviso selected from: Rc is not hydrogen; Rb3 is hydrogen; V is not N; and X-(Z)n is not ethoxy. Representative compounds include 4-(4-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)phenoxy)-N,N-dimethylpiperidine-1-carboxamide; 2-(4-(1-acetylpiperidin-4-yloxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one; 3-(4-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)benzyl)imidazolidine-2,4-dione; (S)-2-(3,5-dimethyl-4-((5-oxopyrrolidin-2-yl)methoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one; N-(1-(4-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)benzyl)piperidin-4-yl)-N-isopropylacetamide; 2-(4-((4-(isopropylamino)piperidin-1-yl)methyl)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one; and 2-(4-((1H-tetrazol-5-yl)methyl)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one. Also disclosed is a pharmaceutical composition comprising the compound as defined above and a pharmaceutically acceptable carrier, intended for the treatment of cancer or inflammation.
Patent NZ-596330-A (NZ)
Title: Lxr modulators
Inventor: BUSCH BRETT B
IPC: A61K31/4164
Filed: 2010-05-26
Abstract: Disclosed herein are compounds of the formula I for use in the treatment of atherosclerosis, diabletes, Alzheimer's disease, dyslipidemia and related diseases. Preferred embodiments include: 2-(1-(3-chloro-3'-fluoro-4'-(hydroxymethyl)-5'-(methylsulfonyl)biphenyl-4-yl)-2-(2-(2,6-dichlorophenyl)propan-2-yl)1H-imidazol-4-yl)propan-2-ol; 2-(2-(2-(2-chloro-3-fluorophenyl)propan-2-yl)-1-(3'-fluoro-4'-(hydroxymethyl)-5'-methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-yl)propan-2-ol; and 2-(2-(2-(2,6-dichlorophenyl)propan-2-yl)-1-(3'-fluoro-4'-hydroxymethyl)-5'-(methylsulfonyl)biphenyl-4-yl)-1H-imdazol-4-yl)propan-2-ol.
Patent NZ-603711-A (NZ)
Title: Tire inflation system with discrete deflation circuit
Inventor: WILSON MATT
IPC: B60C23/10
Filed: 2011-07-29
Abstract: A vehicle tire inflation system (10) includes an air supply source (12) in fluid communication with multiple tires (14) of the vehicle. A pneumatic conduit (C) extends between and is in fluid communication with the air supply source and the tires. Means are fluidly connected to the pneumatic conduit for enabling selective inflation and deflation of the tires. The means include a first pneumatic circuit (15) for inflation of the tires, and a second pneumatic circuit (16) for deflation of the tires. The second pneumatic circuit is discrete from the first pneumatic circuit and is common to more than one of the tires. The means provides controlled deflation of the tires in the second pneumatic circuit based upon a predetermined condition, preventing deflation of the tires until the vehicle is parked, or limiting the deflation of the tires, which in turn enables the tire inflation system to accommodate a desirable increased pressure in the tires.
Patent NZ-605307-A (NZ)
Title: Antibiotic formulations
Inventor: ALAWI FADIL AL
IPC: A61P31/04
Filed: 2011-12-23
Abstract: 605307 Disclosed is a suspension formulation for administration to an animal, the suspension formulation including: at least one cephalosporin antibiotic or a pharmaceutically similar salt thereof; an oil; and a glycerol acetate solvent characterised in that the glycerol acetate solvent is included in the formulation in the range of 0.05 – 5% w/v. Also disclosed is a PET (polyethylene teraphthate) container comprising the suspension. The suspension is useful in treating or preventing bacterial infections such as bovine bacterial respiratory disease, swine bacterial respiratory disease, foot rot or metritis. Further disclosed is a method for preparing the suspension.